drugset / Trial / NCT00877903
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the present study is to establish the safety and efficacy of Prochymal® following first acute myocardial infarction.
Timeline
- Start
- 2009-03-30
- Primary completion
- 2011-05-18
- Completion
- 2016-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prochymal® | Cell therapy | 2e+08 cells | Intravenous |